Effects of early empagliflozin in acute decompensated HFrEF on ventricular systolic and diastolic parameters: interaction with endothelial function and arterial stiffness

Back

ESC2025 Premium Access

Effects of early empagliflozin in acute decompensated HFrEF on ventricular systolic and diastolic parameters: interaction with endothelial function and arterial stiffness

Session: Multidisciplinary approach to heart failure

Topic: Pharmacotherapy

Speaker: Doctor O. Katsarou (Athens, GR)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Ourania Katsarou

Sotiria Thoracic Diseases Hospital of Athens, Athens (Greece)

0 follower

6 more presentations in this session

Guideline-directed medical therapy presciption after acute heart failure hospitalization in Japan

Speaker: Mr K. Kanaoka (Suita, JP)

New horizons in transthyretin cardiac amyloidosis therapy: A systematic review and meta-analysis of sodium-glucose cotransporter 2 inhibitors efficacy

Speaker: Doctor M. Chacon Quiros (San Jose, CR)

Off-label low-dose therapy in heart failure reduced ejection fraction: can we achieve the benefits of the four pillars?

Speaker: Doctor M. Kim (Seoul, KR)

Cardiovascular effects of preferred HOMe-based EXercise training and extended adherence measures in systolic heart failure

Speaker: Doctor M. Bahls (Greifswald, DE)

Innovative strategies and long-term outcomes in left ventricular assist devices therapy for advanced heart failure

Speaker: Doctor N. Schaeffer (Brooklyn, US)

Access the full session

Multidisciplinary approach to heart failure

Speakers: Doctor O. Katsarou, Mr K. Kanaoka, Doctor M. Chacon Quiros, Doctor M. Kim, Doctor M. Bahls...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources